Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanismsNatarajan, N., Ramprasath, T., Gopas, J., Subbiah, R., Rajendran, P. and Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517, eds. (2022) Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms. Frontiers in Pharmacology (Special Issue), 13. Frontiers.
It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing. Official URL: https://www.frontiersin.org/research-topics/22307/... Abstract/SummaryDuring any infection or injury, inflammation plays a vital role in curing the injured tissues. However, uncontrolled inflammatory responses due to defects in pro-resolution and anti-inflammatory processes can be detrimental and lead to many diseases, including gastrointestinal, liver, lung and brain disorders. Although many approved anti-inflammatory drugs are currently in clinical use, long-term usage of anti-inflammatory drugs is associated with many side effects, including gastrointestinal toxicity and adverse effects on the cardiovascular system. Hence, understanding and advancing in the field of small molecules is a better way to tackle this clinical problem with anti-inflammatory drugs. This special issue has collectively published research and review articles focusing on inflammation and small molecule therapeutics with a larger perspective to generate ideas for future scientific and clinical research. We are hopeful that the small molecule-based therapeutic approaches discussed here will evolve more into routine clinical practice in near future.
Download Statistics DownloadsDownloads per month over past year Deposit Details University Staff: Request a correction | Centaur Editors: Update this record |